Dr. Claiborne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 N Broadway
Suite 600
Baltimore, MD 21287Phone+1 410-955-8893Fax+1 410-367-2194
Education & Training
- Johns Hopkins UniversityFellowship, Medical Oncology, 2023 - 2026
- University of MarylandResidency, Internal Medicine, 2020 - 2023
- Virginia Commonwealth University School of MedicineClass of 2020
Certifications & Licensure
- MD State Medical License 2024 - 2026
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Recent trends in diabetes-related consumer health information technology researchJohn Preston Claiborne, Claire A. Wellbeloved-Stone, Rupa S. Valdez
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2019-07-01 - 18 citationsManaging post allograft relapse of myeloid neoplasms: azacitidine and donor lymphocyte infusions as salvage therapy.John Preston Claiborne, Dipankar Bandyopathyay, Catherine H. Roberts, Kelly G. Hawks, May Aziz
Leukemia & Lymphoma. 2019-05-03
Journal Articles
- Use of immune checkpoint inhibition and conventional chemotherapy for multiple, concurrent malignancies post-lung transplantation: A case reportClaiborne JP, Mirkheshti N, Koka R, Timofte IL, Cullen KJ, Current Problems in Cancer: Case Reports, 6/2022
Abstracts/Posters
- Recent trends in diabetes-related consumer health information technology researchClaiborne JP, Wellbeloved-Stone C, Valdez RS, Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Berlin, Germany, 7/26/2019
- Chronic graft-versus-host disease and disease status at relapse as predictors of clinical outcomes in patients receiving azacitidine & donor lymphocyte infusions as sa...Claiborne J, Roberts C, Hawks K, Bandyopadhyay D, Simmons G, Wiedl C, Chung H, Clark W, McCarty J, Toor A, ASBMT BMT Tandem Meetings, Salt Lake City, UT, 2/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: